Innovative Eyewear (LUCY) Competitors $2.20 +0.20 (+10.00%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$2.18 -0.02 (-0.91%) As of 05:27 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LUCY vs. PSTV, PYPD, MLSS, COCH, VVOS, CLGN, FEMY, DRIO, PETV, and RVPShould you be buying Innovative Eyewear stock or one of its competitors? The main competitors of Innovative Eyewear include Plus Therapeutics (PSTV), PolyPid (PYPD), Milestone Scientific (MLSS), Envoy Medical (COCH), Vivos Therapeutics (VVOS), CollPlant Biotechnologies (CLGN), Femasys (FEMY), DarioHealth (DRIO), PetVivo (PETV), and Retractable Technologies (RVP). These companies are all part of the "medical equipment" industry. Innovative Eyewear vs. Its Competitors Plus Therapeutics PolyPid Milestone Scientific Envoy Medical Vivos Therapeutics CollPlant Biotechnologies Femasys DarioHealth PetVivo Retractable Technologies Innovative Eyewear (NASDAQ:LUCY) and Plus Therapeutics (NASDAQ:PSTV) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and valuation. Which has stronger earnings and valuation, LUCY or PSTV? Innovative Eyewear has higher earnings, but lower revenue than Plus Therapeutics. Innovative Eyewear is trading at a lower price-to-earnings ratio than Plus Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInnovative Eyewear$1.64M6.13-$7.77M-$3.99-0.55Plus Therapeutics$5.82M5.64-$12.98M-$2.94-0.18 Does the media prefer LUCY or PSTV? In the previous week, Plus Therapeutics had 4 more articles in the media than Innovative Eyewear. MarketBeat recorded 10 mentions for Plus Therapeutics and 6 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 0.97 beat Plus Therapeutics' score of 0.63 indicating that Innovative Eyewear is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Plus Therapeutics 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders believe in LUCY or PSTV? 1.0% of Innovative Eyewear shares are owned by institutional investors. Comparatively, 3.3% of Plus Therapeutics shares are owned by institutional investors. 1.7% of Innovative Eyewear shares are owned by company insiders. Comparatively, 0.8% of Plus Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts rate LUCY or PSTV? Plus Therapeutics has a consensus target price of $10.83, indicating a potential upside of 1,898.03%. Given Plus Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Plus Therapeutics is more favorable than Innovative Eyewear.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innovative Eyewear 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Plus Therapeutics 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has more volatility & risk, LUCY or PSTV? Innovative Eyewear has a beta of 3.21, suggesting that its share price is 221% more volatile than the S&P 500. Comparatively, Plus Therapeutics has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Is LUCY or PSTV more profitable? Innovative Eyewear has a net margin of -443.18% compared to Plus Therapeutics' net margin of -520.90%. Plus Therapeutics' return on equity of 0.00% beat Innovative Eyewear's return on equity.Company Net Margins Return on Equity Return on Assets Innovative Eyewear-443.18% -86.90% -81.36% Plus Therapeutics -520.90%N/A -202.73% SummaryPlus Therapeutics beats Innovative Eyewear on 9 of the 16 factors compared between the two stocks. Get Innovative Eyewear News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LUCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LUCY vs. The Competition Export to ExcelMetricInnovative EyewearMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.15M$10.54B$5.61B$9.84BDividend YieldN/A1.94%4.61%4.07%P/E Ratio-0.5519.6430.2925.74Price / Sales6.1329.26470.61115.79Price / CashN/A24.6838.2159.48Price / Book0.593.088.866.15Net Income-$7.77M$209.94M$3.25B$265.06M7 Day Performance12.24%6.22%3.72%2.60%1 Month Performance1.85%12.43%5.86%2.83%1 Year Performance-44.72%-8.96%30.49%25.58% Innovative Eyewear Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LUCYInnovative Eyewear0.8596 of 5 stars$2.20+10.0%N/A-44.6%$9.15M$1.64M-0.559News CoverageEarnings ReportShort Interest ↓High Trading VolumePSTVPlus Therapeutics2.8372 of 5 stars$0.74+26.3%$10.83+1,365.7%-61.8%$35.39M$5.82M-0.2520News CoverageEarnings ReportShort Interest ↓Gap UpHigh Trading VolumePYPDPolyPid3.0334 of 5 stars$3.44+0.9%$11.80+243.0%-1.7%$34.75MN/A-0.8080Trending NewsEarnings ReportAnalyst ForecastShort Interest ↓MLSSMilestone Scientific2.3344 of 5 stars$0.55+27.7%$1.25+127.3%-42.1%$33.80M$8.61M-7.8630News CoverageShort Interest ↑Gap UpHigh Trading VolumeCOCHEnvoy Medical3.48 of 5 stars$1.43-1.0%$9.25+546.9%-47.1%$30.82M$220K-1.0034Negative NewsVVOSVivos Therapeutics0.8711 of 5 stars$4.76-8.1%$4.82+1.2%+94.5%$30.51M$15.03M-2.75160News CoverageGap DownCLGNCollPlant Biotechnologies2.8948 of 5 stars$2.25-1.7%$11.50+411.1%-41.9%$29.13M$510K-1.8470Upcoming EarningsFEMYFemasys2.964 of 5 stars$0.81-1.4%$8.67+972.2%-30.0%$26.66M$1.70M-0.8930Earnings ReportShort Interest ↑Analyst RevisionGap UpDRIODarioHealth1.4778 of 5 stars$0.55+0.0%$2.00+263.6%-51.6%$25.03M$27.04M-0.98200News CoverageGap DownPETVPetVivoN/A$0.80-1.0%N/A+39.5%$22.00M$1.05M-1.7820News CoverageRVPRetractable Technologies1.9945 of 5 stars$0.73-1.7%N/A-26.2%$21.86M$33.75M-1.35240News CoverageShort Interest ↑Gap Up Related Companies and Tools Related Companies PSTV Competitors PYPD Competitors MLSS Competitors COCH Competitors VVOS Competitors CLGN Competitors FEMY Competitors DRIO Competitors PETV Competitors RVP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LUCY) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovative Eyewear, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovative Eyewear With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access